Bio

Academic Appointments

Administrative Appointments

  • President, Medical Staff (2005 - 2007)

Honors & Awards

  • Fellow, American College of Cardiology (1980)
  • Member, Academy of Anesthesiology (2002)
  • Distinguished Service Award, California Society of Anesthesiologists (2005)
  • Honorary Life Membership, California Society of Anesthesiologists (1995)
  • Listee, Best Doctors in America (1996-2007)
  • Resolution Awardee, California State Legislature Assembly (1995)

Contact

Publications

All Publications

  • Care management and technology enhance care delivery. Medical group management journal FICKENSCHER, K. M., Garman, J. K. 1999: 30-32

    Abstract

    Many health care delivery organizations have experienced a flattening in the rate of their ability to decrease health care costs. Providers--if they are willing to take responsibility for care management and make appropriate investments to support the initiatives--are the logical party to take responsibility for improving care and cost control. Taking responsibility for care management, however, requires the tactical deployment of information technology to enhance care management. This article outlines what is required for information technology to improve care and cut costs.

    View details for PubMedID 10788080

  • Optimal pressures and flows during cardiopulmonary bypass. Pro: a low-flow, low-pressure technique is acceptable. Journal of cardiothoracic and vascular anesthesia Garman, J. K. 1991; 5 (4): 399-401

    View details for PubMedID 1873520

  • USE OF A CHLORHEXIDINE DRESSING TO REDUCE MICROBIAL COLONIZATION OF EPIDURAL CATHETERS ANESTHESIOLOGY Shapiro, J. M., Bond, E. L., Garman, J. K. 1990; 73 (4): 625-631

    Abstract

    We performed a prospective randomized controlled trial to assess the efficacy of a chlorhexidine dressing in reducing the microbial flora at the insertion site of epidural catheters. These catheters were used for acute pain management and were dressed either by a standardized method or with a CHX/urethane sponge composite. Microbial colonization of the catheter developed in 9 of 31 controls (29.0%) and 1 of 26 (3.8%) catheters with the CHX dressing (P less than 0.05%). The CHX dressing caused no adverse effects. The data suggest that delivery of antiseptic to the catheter wound site reduces catheter colonization with a possible reduction in the risk of epidural catheter-related infection.

    View details for Web of Science ID A1990EB62300007

    View details for PubMedID 2121070

  • TOO HOT TO HANDLE - A LARYNGOSCOPE MALFUNCTION ANESTHESIOLOGY Siegel, L. C., Garman, J. K. 1990; 72 (6): 1088-1089

    View details for Web of Science ID A1990DH68800022

    View details for PubMedID 2350024

  • AN ATTACHABLE SILVER-IMPREGNATED CUFF FOR PREVENTION OF INFECTION WITH CENTRAL VENOUS CATHETERS - A PROSPECTIVE RANDOMIZED MULTICENTER TRIAL AMERICAN JOURNAL OF MEDICINE Maki, D. G., Cobb, L., Garman, J. K., Shapiro, J. M., Ringer, M., Helgerson, R. B. 1988; 85 (3): 307-314

    Abstract

    Percutaneously inserted central venous catheters are widely used. Catheter-related bacteremia or fungemia is the most frequent serious complication of these catheters. In an attempt to reduce the frequency of such infections, a subcutaneous cuff constructed of a biodegradable collagen matrix impregnated with bactericidal silver was developed. Our goal was to assess, in a multicenter clinical trial, the effectiveness of this cuff in preventing catheter-related infection.Central venous catheters needed for fluid or drug therapy, hemodynamic monitoring, or hyperalimentation in patients in three centers were randomly assigned to be inserted with or without the cuff. Patients and catheters in the two groups were comparable in terms of risk factors predisposing to infection, including colonization of skin about the insertion site.The results with 234 catheters inserted into a new site showed that catheters inserted with the cuff were threefold less likely to be colonized on removal (more than 15 colony-forming units) than were control catheters (28.9 percent versus 9.1 percent, p = 0.002) and were nearly fourfold less likely to produce bacteremia (3.7 percent versus 1.0 percent). Adverse effects from the cuff were not seen. The cuff did not confer protection, however against infection with catheters inserted over a guidewire into old sites. Most of the catheter-related infections identified in this study, including four of the six bacteremias, appear to have been caused by microorganisms colonizing skin about the insertion site, affirming the pathogenetic basis for benefit seen with the cuff in this clinical trial; two may have derived from contamination of the catheter hub.This novel, silver-impregnated, attachable cuff can substantially reduce the incidence of catheter-related infection with most percutaneously inserted central venous catheters, can extend the time catheters can be left in place safely, and can prove cost-beneficial.

    View details for Web of Science ID A1988Q014700005

    View details for PubMedID 3046351

  • ANESTHESIA FOR CARDIAC TRANSPLANTATION CLEVELAND CLINIC QUARTERLY Garman, J. K. 1981; 48 (1): 142-146

    View details for Web of Science ID A1981LV01000027

    View details for PubMedID 7021000

  • ARE ANESTHESIOLOGISTS EXPERTS IN CARDIOPULMONARY RESUSCITATION ANESTHESIOLOGY Garman, J. K. 1979; 50 (3): 182-184

    View details for Web of Science ID A1979GP62000002

    View details for PubMedID 434500

  • EFFECTS OF INNOVAR ON FUNCTIONAL RESIDUAL CAPACITY AND TOTAL CHEST COMPLIANCE IN MAN ANESTHESIOLOGY KALLOS, T., Wyche, M. Q., Garman, J. K. 1973; 39 (5): 558-561

    View details for Web of Science ID A1973R294200020

    View details for PubMedID 4746064

  • ELECTROENCEPHALOGRAPHIC PATTERN DURING ANESTHESIA WITH ETHRANE - EFFECTS OF DEPTH OF ANESTHESIA, PACO2, AND NITROUS OXIDE ANESTHESIOLOGY NEIGH, J. L., Garman, J. K., HARP, J. R. 1971; 35 (5): 482-?

    View details for Web of Science ID A1971K686500005

    View details for PubMedID 5098697

Footer Links:

Home | Stanford Medicine

Latest information on COVID-19

COVID-19 Updates

Stanford Medicine is closely monitoring the COVID-19 pandemic. Get the latest news on COVID-19 testing, treatment, tracking data, and medical research.

Health Care

Healing through compassion and world-class science

Research

Fueling discovery and innovation to advance human health

Education

Empowering tomorrow's leading physicians and scientists

Students

MD Admissions

Diversity

MD Program

PhD Program

Dual-Degree Programs

Masters Programs

RACIAL JUSTICE

Our Pledge

Racism and discrimination are direct affronts to Stanford Medicine?s values. Read our leaders? pledge on racial equity.

About
Stanford Medicine

A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies.

Cancer diagnoses increase at 65, study finds

Analyzing a national cancer database, Stanford Medicine researchers find a bump in diagnoses at 65, suggesting that many wait for Medicare to kick in before they seek care.

covid-19 research at Stanford Medicine

Our scientists have launched dozens of research projects as part of the global response to COVID-19. Some aim to prevent, diagnose and treat the disease; others aim to understand how it spreads and how people?s immune systems respond to it.
community

Team aids Lakota Nation in fighting COVID-19

A Stanford Medicine team offered guidance in crafting a COVID-19 response for the Oglala Lakota Nation.
education

Medical students meet their matches

Medical students recently learned where they would be heading for their residencies.
patient care

A champion of equity in patient care

Sharon Hampton is focusing on patient equity as a nursing leader at Stanford Health Care. Getting to know patients and staff is key, she says.

Stanford Medicine Resources: